Ovarian cancer test nearly 100% accurate

Ovarian cancer is a silent killer that displays few obvious symptoms. But researchers from the Georgia Institute of Technology may have the answer for detecting the disease early. In a recent study, they detected ovarian cancer from blood samples with near 100 percent accuracy. "Because ovarian cancer is a disease of relatively low prevalence, it's essential that tests for it be extremely accurate. We believe we may have developed such a test," says John McDonald, chief research scientist...

Curis shares sink as Genentech evaluates lead drug’s fate

Investigators at Roche and Genentech are preparing an in-depth analysis of a fresh crop of mid-stage data on Curis's GDC-0449, with an eye to determine whether the therapy should make the cut for ovarian cancer--less than two months after the same therapy flunked its mid-stage trial for colon cancer. "Following these analyses," wrote Curis (CRIS) in a clinical update, "they (Roche and Genentech) expect to make a portfolio decision regarding whether, or to what extent, they will continue...